<DOC>
	<DOCNO>NCT01911468</DOCNO>
	<brief_summary>The purpose study determine whether combined treatment liraglutide metformin effective liraglutide metformin monotherapy treatment obese woman polycystic ovary syndrome ( PCOS ) previously poor responder regard weight reduction metformin monotherapy . We anticipate great change body weight patient combine treatment monotherapy liraglutide metformin .</brief_summary>
	<brief_title>Polycystic Ovary Syndrome Liraglutide Add-on Therapy Metformin</brief_title>
	<detailed_description />
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>18 year old menopause polycystic ovary syndrome ( NICHD criterion ) BMI 30 kg/mÂ² high poor response previous treatment metformin least 3 month type 1 type 2 diabetes mellitus history carcinoma Cushing 's syndrome congenital ( nonclassic ) adrenal hyperplasia personal family history MEN 2 significant cardiovascular , kidney hepatic disease use medication know suspected affect reproductive metabolic function use statin , within 90 day prior study entry</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>PCOS</keyword>
	<keyword>obesity</keyword>
	<keyword>GLP-1 receptor agonist</keyword>
	<keyword>liraglutide</keyword>
	<keyword>metformin</keyword>
</DOC>